Effect of long-term trimethoprim/sulfamethoxazole treatment on resistance and integron prevalence in the intestinal flora: a randomized, double-blind, placebo-controlled trial in children | Zendy

Elly L. van der Veen | Zendy; Anne GM Schilder | Zendy; Tim K. Timmers | Zendy; Maroeska M. Rovers | Zendy; Ad C. Fluit | Zendy; Marc J. M. Bonten | Zendy; Maurine A. Leversteinvan Hall | Zendy

Open Access

Effect of long-term trimethoprim/sulfamethoxazole treatment on resistance and integron prevalence in the intestinal flora: a randomized, double-blind, placebo-controlled trial in children

Author(s) -

Elly L. van der Veen,

Anne GM Schilder,

Tim K. Timmers,

Maroeska M. Rovers,

Ad C. Fluit,

Marc J. M. Bonten,

Maurine A. Leversteinvan Hall

Publication year - 2009

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkp050

Subject(s) - trimethoprim , sulfamethoxazole , placebo , population , medicine , antibacterial agent , microbiology and biotechnology , integron , antibiotics , enterobacteriaceae , biology , antibiotic resistance , escherichia coli , pathology , environmental health , alternative medicine , biochemistry , gene

The aim of this study was to test the hypothesis that trimethoprim/sulfamethoxazole selects for integron-positive and multidrug-resistant Enterobacteriaceae in the intestinal flora.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research